Multiple sclerosis and neuroinflammation
The sponsor supports clinical research in multiple sclerosis across relapsing and progressive forms, with attention to inflammatory activity, imaging markers, and chronic disease burden.
- Secondary progressive multiple sclerosis
- Relapsing-remitting multiple sclerosis
- Active progressive multiple sclerosis
- Compartmentalized inflammation and meningeal inflammation
Research interests include MRI markers, cerebrospinal fluid analysis, and immunological features linked to persistent central nervous system inflammation.
Parkinson’s disease and motor complications
Clinical activity includes studies in Parkinson’s disease with motor fluctuations, with interest in symptom control and treatment of disease-related pain.
- Parkinson’s disease with motor fluctuations
- PD-related pain
- Motor symptom management
The therapeutic focus extends to non-motor manifestations that affect daily function and quality of life in people living with Parkinson’s disease.
Cystic fibrosis and respiratory infection
The sponsor is involved in cystic fibrosis research, including patients without currently eligible CFTR modulator options and those affected by persistent bacterial infection.
- Cystic fibrosis
- Persistent Staphylococcus aureus infection
- MRSA-associated respiratory disease
- Antibacterial inhaled therapy
These studies address pulmonary infection control and treatment options for individuals with limited mutation-specific therapeutic access.
Oncology in gastric and peritoneal disease
Research activity includes gastric adenocarcinoma with peritoneal metastases, reflecting interest in advanced gastrointestinal malignancy and regional treatment strategies.
- Gastric adenocarcinoma
- Peritoneal metastases
- Multimodal cancer therapy
- Radical-intent surgery
The oncology portfolio also includes work relevant to peritoneal disease and treatment pathways for patients with limited metastatic spread.
Pediatric neurology and spasticity
The sponsor funds studies in children with cerebral palsy and multifocal spasticity affecting both upper and lower limbs.
- Cerebral palsy
- Upper limb spasticity
- Lower limb spasticity
- Botulinum toxin-based treatment
Clinical interest centers on functional impairment in pediatric neuromotor disorders and management of spasticity across multiple limb regions.
